SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (1210)11/20/2003 12:57:25 PM
From: tuck  Read Replies (2) of 1784
 
MDCC is the current gorilla in the ion channel/patch clamp space, but Sweden's Cellectricon threatens. MDCC might consider munching them.

the-scientist.com

This article seems to ignore the throughput the IonWorks HT system is capable of -- also thousands of patches per day (see referenced post) -- nevertheless, with several big pharmas already Cellectricon customers, it's very much a horse race in this market. If memory serves (can't find my notes) MDCC has called this a $500 million market opportunity.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News